Algernon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Algernon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Algernon Today - Breaking & Trending Today

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it plans to move forward with its intravenous formulation of its AP-188 (“N,N-Dimethyltryptamine” or “DMT”) stroke research program as its lead asset, after having sold its Ifenprodil research program for USD $2M cash and a 20% common share ....

British Columbia , United Kingdom , Christopherj Moreau , Company Or Algernon , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Centre For Human Drug Research , Company Phase , Algernon Neuroscience , Stroke Study , Human Drug Research , Algernon Pharmaceuticals Inc , Clinical Trial Design , Research Program , Algernon Neuroscience ,

The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / January 9, 2023 / The Power Play by The Market Herald has announced the release of a new interview with Algernon Pharmaceuticals discussing their latest news.The Power Play ....

British Columbia , Christopherj Moreau , Sabrina Cuthbert , Terms Of Service , Card Canada Media Ltd , Market Herald , Algernon Pharmaceuticals , Power Play , Market Herald Canada , Report Card Canada Media , Market Herald Limited , Report Card , Privacy Policies , Market Heraldview ,

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study

VANCOUVER, British Columbia, Oct. 24, 2022 Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has entered an. | October 24, 2022 ....

United States , United Kingdom , Yale School , British Columbia , Christopherj Moreau , Deepak Cyril Dsouza , Deepak Dsouza , No Securities Exchange , Yale University , Yale School Of Medicine , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Neither The Canadian Securities Exchange , Yale University School Of Medicine , Company Or Algernon , Canadian Securities Exchange , Schizophrenia Neuropharmacology Research Group , Globenewswire Inc , Investigator Initiated Clinical Trial Agreement , Professor Deepak Cyrild Souza , United States Government , Deepakd Souza , Neuropharmacology Research Group , University School , Market Regulator , Algernon Pharmaceuticals Inc Stock Exchange ,

Microdose Psychedelic Insights: Microdose Announces Algernon Pharmaceuticals as Wonderland's Headline Sponsor

Miami, Florida (Newsfile Corp. - September 8, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is thrilled to announce Algernon Pharmaceuticals (CSE: AGN) (FSE: ....

United States , Christopherj Moreau , Patrick Moher , Mana Wynwood Convention Centre In Miami Arts , Centre For Human Drug Research , Leiden University Medical Center , Algernon Pharmaceuticals , Constraint Induced Movement Therapy , Florida Newsfile Corp , Algernon Pharmaceuticals Inc , Psychedelic Insights , Headline Sponsor , Mana Wynwood Convention Centre , Session Keynote November , Microdose Psychedelic , Human Drug Research , Constraint Induced Movement ,